Clinical trial

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

NCT04829903

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Dulaglutide Normalized identity: dulaglutideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Liraglutide Normalized identity: liraglutideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-01-02

PhaseNA

Conditions

Type 2 Diabetes Treated With Insulinunresolved

Obesityverified · MONDO: obesity disorder

Adolescent Obesityunresolved

Interventions

DulaglutideDRUG · verified · RxNorm: dulaglutide

LiraglutideDRUG · verified · RxNorm: liraglutide

Sponsors & collaborators

Corporacion Parc Taulilead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04829903 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.